[The neurotropic and myotropic properties of fucidin].
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000284:Administration, Oral; D000818:Animals; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D000697:Central Nervous System Stimulants / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D004357:Drug Synergism; D005672:Fusidic Acid / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D005769:Gastrointestinal Motility / Q000187:drug effects; D007275:Injections, Intravenous; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009069:Movement Disorders / Q000139:chemically induced; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D009420:Nervous System / Q000187:drug effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology; D009541:Nictitating Membrane / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D011817:Rabbits; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000517:prevention & control; D013331:Strychnine / Q000037:antagonists & inhibitors; D014630:Vagus Nerve / Q000187:drug effects
D000697:Central Nervous System Stimulants; D003473:Neuromuscular Nondepolarizing Agents; D005672:Fusidic Acid; D013331:Strychnine; D000109:Acetylcholine; D010433:Pentylenetetrazole
O neĭrotropnykh i miotropnykh svoĭstvakh fuzidina